Last summer, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes and in adults with type 2 diabetes. The FDA granted approval for insulin glargine-yfgn to Mylan Pharmaceuticals Inc., who is marketing the product as Semglee. Semglee...
Positive results from the Phase III LINC 4 study have confirmed the efficacy and safety of osilodrostat, an oral therapy for patients with Cushing’s disease. The results were published in The Journal of Clinical Endocrinology & Metabolism. Recordati Rare Diseases is marketing the drug as ISTURISA®. The LINC 4 study augments the efficacy and safety...
Oral Medication Shows Benefits Treating Type 1 Diabetes for at Least Two Years after Diagnosis
Use of the drug verapamil to treat type 1 diabetes continues to show benefits lasting at least two years, according to a recent report in Nature Communications. Patients taking the oral blood pressure medication not only required less daily insulin two years after first diagnosis of the disease, but also showed evidence of surprising immunomodulatory benefits....
Strategic Partnership Will Bring Digital Health Innovation to the Hospital Bedside
Glytec and Roche Diagnostics USA last month announced a digital health collaboration that combines Roche’s expertise in medical devices and IT solutions with Glytec’s FDA-cleared insulin dosing decision support software, Glucommander™, to address the pervasive challenges with inpatient blood sugar management at the hospital bedside. Glucommander will be the first software application available to run...
The U.S. Food and Drug Administration (FDA) last month approved a rechargeable neurostimulator and a recharge-free neurostimulator for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN). Medtronic is marketing the products as Intellis™ and Vanta™, respectively. DPN is a debilitating and progressive neurological disorder that affects approximately 30% of people with diabetes,...
Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. Here is part 2 of Endocrine News’s closer look at some of the endocrine science innovations announced throughout 2021. Endocrine researchers and clinicians continued to remain at the forefront of medical research, the result of which... Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. From remarkable new treatments for acromegaly, thyroid eye disease, hypoglycemia, and diabetes to new devices aimed at glucose monitoring in adults and children, a mail-in semen analysis kit, and much more, Endocrine News takes a closer... In November, the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the granting of a marketing authorization for Ascendis Pharma’s lonapegsomatropin (TransCon hGH), a long-acting once-weekly, transiently pegylated somatropin that in the body releases somatropin, indicated for growth failure in children and adolescents aged from 3 years...
If you are looking for a resource to ensure your endocrinology practice is up to date with legal and medical news, want to ensure you are meeting your patients’ needs to the best of your ability, and wish to be aware of recent advances in endocrinology, then Endocrine News has the right tools for you. Our Practice page is dedicated to providing information that is helpful and insightful for those running an endocrinology practice. Here you will find a collection of articles that provide current, relevant and vital information to help with your decisions as you run your practice.
Stay Current with Recent Advances in Endocrinology
As new technology hits the medical world and new discoveries about the endocrine system are made, you need the right information to continue to provide your patients with skilled medical care. Here you will find updated news and information about advances in the field, consolidated into one convenient location to help you save time while staying current. Rather than monitoring several news sites and digging for pertinent information, you can simply visit one page and have it all at your fingertips — saving you time as you run a busy practice.
See Clinical Endocrinology News That’s Relevant to Your Practice
On Endocrine News, you will also find the clinical news specific to the field of endocrinology that will help you make the best possible decisions for your clinic and your patients. From recent discoveries to research studies, you will have access to the most accurate and recent information available in the field. All of the reports, results and studies you need to see are here for you to search.
Improve Your Practice with Industry-Specific Tips and Tricks
In addition to the technical and medical industry research and reports you will find here, Endocrine News has the resources you need to keep your practice profitable and effective. From legal advice and tips to time management and patient interaction recommendations, you’ll find advice, insight and more that will help you run an efficient clinic that keeps your patients’ needs at the forefront of all you do.
